Patents by Inventor Barbara Wildhaber

Barbara Wildhaber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREPARING INDUCED HEPATIC PROGENITOR CELLS
    Publication number: 20190177696
    Abstract: The present invention relates to a method for preparing induced hepatic progenitor cells (iHPC) comprising the steps of dedifferentiation of hepatocytes by culture with a culture medium comprising at least one activator of the Wnt signaling, Basic fibroblast growth factor (b-FGF), and Epidermal growth factor (EGF).
    Type: Application
    Filed: June 16, 2017
    Publication date: June 13, 2019
    Inventors: Carmen UNZU EZQUERRO, Marc FRIEDLI, Didier TRONO, Barbara WILDHABER
  • Compositions and methods for treatment and prevention of gastrointestinal disorders
    Publication number: 20070123499
    Abstract: The present invention provides compositions and methods for treating and preventing inflammatory bowel disease and other gastrointestinal disorders (e.g., mucositis, radiation induced enteritis, and short bowel syndrome). In particular, the present invention provides methods of treating and preventing symptoms of inflammatory bowel disease and other gastrointestinal disorders using compositions comprising an angiotensin converting enzyme (ACE) inhibitor and polyethylene glycol.
    Type: Application
    Filed: October 3, 2006
    Publication date: May 31, 2007
    Applicant: Regents of the University of Michigan
    Inventors: Daniel Teitelbaum, Barbara Wildhaber, Hua Yang
  • Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders
    Publication number: 20050203168
    Abstract: The present invention provides compositions and methods for treating and preventing inflammatory bowel disease and other gastrointestinal disorders (e.g., short bowel syndrome). In particular, the present invention provides methods of treating symptoms of inflammatory bowel disease and other gastrointestinal disorders using angiotensin converting enzyme (ACE) inhibitors.
    Type: Application
    Filed: March 11, 2004
    Publication date: September 15, 2005
    Applicant: The Regents of the University of Michigan
    Inventors: Daniel Teitelbaum, Barbara Wildhaber